Clinical Trial

ActiTENS Mini (Transcutaneous Electrical Stimulation) in Women With Chronic Pain From Pelvic Endometriosis

Study acronym: ENDOTENS
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Endometriosis is a condition that often causes pelvic pain, particularly during menstruation but also continuously and over long periods. Pharmacological treatments are only moderately effective or are associated with adverse effects. In this context, the search for non-pharmacological approaches to endometriosis pain is essential. Transcutaneous electrical nerve stimulation (TENS) is a portable pain relief technique that is rapidly developing for the treatment of endometriosis pain. The protocol presented aims to confirm the analgesic efficacy of this treatment for endometriosis pain. It will involve 27 gynecology and pain departments in mainland France. It will offer 30-minute sessions of daily stimulation, either suprapubic or lumbar. Several types of stimulation will be compared, with three 3-month phases, two blind phases, and a 3-month phase in which the system used will be fixed. The aim will be to reduce pain intensity as well as other parameters relating to quality of life and the impact of pain. If the effectiveness of this device is confirmed, it could lead to TENS being made available for endometriosis pain and potentially prescribed by gynecologists and midwives.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-19.
Trial Details
NCT Number NCT07317037
Lead Sponsor Assistance Publique - Hôpitaux de Paris
Collaborators: SUBLIMED (Donation of DMs and application development), Ministry of Health, France
Conditions Endometriosis
Enrollment 208 participants
Start Date 2026-03-01
Primary Completion 2027-12-01 (estimated)
Study Completion 2028-08-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-07